Acurable Revenue and Competitors
Estimated Revenue & Valuation
- Acurable's total funding is $14M.
Employee Data
- Acurable has 33 Employees.
- Acurable grew their employee count by 38% last year.
Acurable's People
Name | Title | Email/Phone |
---|---|---|
1 | Head Engineering and Co-Founder | Reveal Email/Phone |
2 | co-CEO & CSO | Reveal Email/Phone |
3 | co-CEO & COO | Reveal Email/Phone |
4 | Head Platform | Reveal Email/Phone |
5 | Head Platform | Reveal Email/Phone |
6 | Commercial Director Europe | Reveal Email/Phone |
7 | HR and People Ops Manager | Reveal Email/Phone |
8 | Clinical Development Manager | Reveal Email/Phone |
9 | Research Scientist | Reveal Email/Phone |
10 | Product Development Coordinator | Reveal Email/Phone |
Acurable Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 23 | -36% | N/A | N/A |
#2 | N/A | 12 | 9% | N/A | N/A |
#3 | N/A | 9 | 0% | N/A | N/A |
#4 | N/A | 33 | 38% | $13.6M | N/A |
#5 | N/A | 35 | 21% | $1.72M | N/A |
#6 | N/A | 24 | 14% | $4.31M | N/A |
What Is Acurable?
Acurable is a fast-growing, venture backed MedTech start-up with offices in London and Seville. We create accurate and user-friendly wearable medical devices intended to be used by patients at home. Our award-winning, patented technology enables for the first time the automated diagnosis and management of respiratory conditions. It is the product of more than 10 years’ research at Imperial College London by Acurable’s founder, Professor Esther Rodriguez Villegas, and has been recognised as a breakthrough in respiratory medicine, winning some of the most respected awards in the industry, among them an XPrize and several Innovate UK grants. It has also featured in national and international media, including earlier this year in the BBC Horizon documentary How to Sleep Well with Michael Mosley. In 2020 our first product, AcuPebble SA100, became the first medical device in the world to obtain the CE mark for the automated diagnosis of obstructive sleep apnoea at home, and a few months later the product gained FDA clearance for home sleep apnoea testing in the US. AcuPebble SA100 is now in use within healthcare organisations across the UK and Europe, and will be launching in the USA in the coming months. At the same time we continue our research to develop new products that will fundamentally improve the lives of millions of people suffering from serious chronic conditions such as COPD, Asthma and Epilepsy.
keywords:N/A$14M
Total Funding
33
Number of Employees
N/A
Revenue (est)
38%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.8M | 33 | -33% | N/A |
#2 | $3.8M | 33 | 0% | $6M |
#3 | $7.1M | 33 | -8% | N/A |
#4 | $3.2M | 33 | -3% | N/A |
#5 | $3.8M | 33 | 6% | N/A |